Spravato®Registry-verifiedDesignated-centers model

Universitäre Psychiatrische Kliniken Basel (UPK)

Basel, Switzerland

Treatment & access

  • Treatments offeredEsketamine nasal spray (Spravato®)
  • Access routeCovered by a national programme
  • Cost & coverage (registry status)Reimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
  • ReimbursementBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 How reimbursement works in Europe →
  • Phone+41 61 325 51 11
  • Websitehttps://www.upk.ch/

Related listings

These records belong to the same organisation. They are listed separately because each is a distinct programme or location.

About this provider

Universitäre Psychiatrische Kliniken (UPK) Basel is the university psychiatric hospital for the Basel region, based at Wilhelm Klein-Strasse 27. Its Centre for Affective, Stress and Sleep Disorders (ZASS) runs an outpatient clinic for affective disorders and interventional psychiatry, offering outpatient ketamine-based therapy and electroconvulsive therapy for severe and difficult-to-treat depression, alongside inpatient wards for depression and bipolar disorders. Referrals to the outpatient ketamine programme are made by physicians via the ZASS secretariat, and a 24-hour central admission service operates on campus.

Services & programs

  • Centre for Affective, Stress and Sleep Disorders (ZASS)
  • Outpatient clinic for affective disorders and interventional psychiatry
  • Outpatient ketamine therapy (physician referral via ZASS)
  • Electroconvulsive therapy (ECT), outpatient and inpatient
  • Inpatient wards for depression and bipolar disorders
  • 24-hour patient admission and emergency psychiatry

Common questions

How do I access ketamine-based treatment at UPK Basel?

UPK states that outpatient ketamine therapy at the ZASS centre is arranged via specialist physician referral (zass@upk.ch or the secretariat on +41 61 325 50 97). For nasal esketamine (Spravato) under Swiss basic insurance, a treating psychiatrist must confirm eligibility and obtain the insurer's cost approval (Kostengutsprache) before the first dose.

Is Spravato reimbursed by Swiss basic insurance (OKP)?

Yes, under a Limitatio: adults 18-74 with a depressive episode that has not responded to at least two antidepressants plus one augmentation attempt, illness severity CGI-S of 5 or more, prior insurer approval before the first dose, and reimbursement for a maximum of 10 months.

Looking at alternatives? One of the BAG-designated Spravato centers; see the country guide and the limited-medical-use PAT program.

16 more verified providers within 50 km

See them on the provider map →

Practical details

As stated on the provider's own website (checked 2026-09-09); details can change — confirm when you book.

  • Opening hoursWalk-In Ambulanz: Mo–Fr 08:00–16:00; Notfall-Aufnahme 24h täglich Source →

Verification

At least one source for this record is a public state registry or an official public-law register. The registry entry is linked below and re-checked at least every 90 days.

Spotted an error? See our methodology for how records are checked and how to report a correction.

Check your fit & enquire

Spravato® access in Switzerland follows published criteria. A short pre-screening comes first, then your compiled summary goes to Universitäre Psychiatrische Kliniken Basel (UPK) only with your explicit consent, and you can download it for yourself either way.

Why enquire via PsyAccess

  • Pre-screening first. A 2-minute check in your browser shows which legal routes fit your situation, before you reach out to anyone.
  • A structured enquiry. Your enquiry reaches the provider with a structured summary, so the clinic can reply quickly and to the point.
  • Independent & free. Free for patients. We don't charge for enquiries, and no provider pays for placement.
Check my fit & enquire

About two minutes. The check itself runs in your browser: your answers are never sent anywhere unless you choose to send them. We count only anonymous usage events.